Skip to content

AOXING PHARMACEUTICAL COMPANY, INC.

CIK 0001060426

← back to feed
Revenue (TTM)
$9.85M
+22.3% YoY Q3 May 2017
Net Income (TTM)
$1.1M
−62.5% YoY Q3 May 2017
EPS Diluted (TTM)
$0.06
−66.7% YoY Q3 May 2017
Gross Margin
220.3%
Q3 May 2017
Operating Margin
44.1%
Q3 May 2017
Net Margin
11.2%
Q3 May 2017
Free Cash Flow (TTM)
−$4.85M
Q3 May 2017
Cash
$2.74M
Q3 May 2017
Total Debt
$13.74M
Q3 May 2017
Shares Outstanding
76.21M sh
Q3 May 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings